PT  - JOURNAL ARTICLE
AU  - Zhong, Lu
AU  - Diagne, Mamadou
AU  - Wang, Weiping
AU  - Gao, Jianxi
TI  - Country distancing reveals the effectiveness of travel restrictions during COVID-19
AID  - 10.1101/2020.07.24.20160994
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.24.20160994
4099  - http://medrxiv.org/content/early/2020/07/24/2020.07.24.20160994.short
4100  - http://medrxiv.org/content/early/2020/07/24/2020.07.24.20160994.full
AB  - Travel restrictions are the current central strategy to globally stop the transmission of the novel coronavirus disease (COVID-19). Despite remarkably successful approaches in predicting the spatiotemporal patterns of the ongoing pandemic, we lack an intrinsic understanding of the travel restriction’s effectiveness. We fill this gap by developing a surprisingly simple measure, country distancing, that is analogical to the effective resistance in series and parallel circuits and captures the propagation backbone tree from the outbreak locations globally. This approach enables us to map the effectiveness of travel restrictions to arrival time delay (ATD) or infected case reduction (ICR) systematically. Our method estimates that 50.8% of travel restrictions as of Apr-4 are ineffective, resulting in zero ATD or ICR worldwide. Instead, by imposing Hubei’s lockdown on Jan-23 and national lockdown on Feb-8, mainland China alone leads to 11.66 [95% credible interval (CI), 9.71 to 13.92] days of ATD per geographic area and 1,012,233 (95% CI, 208,210 −4,959,094) ICR in total as of Apr-4. Our result unveils the trade-off between the country distancing increase and economic loss, offering practical guidance for strategic actsion about when and where to implement travel restrictions, tailed to the real-time national context.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Department of Mechanical Aerospace and Nuclear Engineering Department at Rensselaer Polytechnic Institute, Troy, NY.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NO clinical trials and interventional studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data needed to evaluate the conclusions in the paper are presented in this paper. Additional data related to this paper may be requested from the authors.